Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBp 1,379.50
+2.50 (0.18%)
Oct 24, 2025, 4:38 PM BST
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 11.69 billion as of October 24, 2025. Its market cap has increased by 23.37% in one year.
Market Cap
11.69B
Enterprise Value
13.72B
Revenue
4.33B
Ranking
n/a
PE Ratio
33.90
Stock Price
1,379.50
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 11.69B, an increase of 1,326.19%. That is a compound annual growth rate of 6.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 11.67B | 35.01% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | 13.22B | -17.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.45B |
| Haleon | 31.57B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.92B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.74B |
| Oxford Nanopore Technologies | 1.38B |